News by Industry
Infectious Disease Control
Releases published in the last 30 days.
Page 1 of 1
- Millions of Children’s Lives at Risk in Collapse of Syrian Health System
- 3/10/2014 3:53:06 PM
- WESTPORT, Conn. — Syria’s shattered health system is forcing health workers to engage in brutal medical practices and a series of epidemics have left millions of children exposed to a plethora of deadly diseases, Save the Children says in a new report. The report, “A Devastating Toll: the Impact of Three Years of War on the Health of Syria’s Children" , sheds light on a …
- Laboratory Offers Testing Services for Exserohilum and Other Fungal Pathogens
- 3/10/2014 9:14:02 AM
- Fungi are a natural part of the environment and can be found all around us, but some can cause infections in people, especially those with a weakened immune system. These pathogenic fungi can sometimes be found in contaminated products and others are commonly associated with mold infested indoor environments. One particular type of fungi has received a great deal of …
- Zoetis Appoints Dr. Willie M. Reed, Dean of the College of Veterinary Medicine at Purdue University, to its Board of Directors
- 3/6/2014 9:49:33 AM
- Zoetis Inc. (NYSE:ZTS) announced the appointment of Dr. Willie M. Reed, Dean of the College of Veterinary Medicine at Purdue University, to its Board of Directors. Dr. Reed will serve on the Corporate Governance Committee of the Board. Dr. Reed has more than 30 years of experience in animal health and veterinary medicine, gained during his tenure at Purdue University and …
- Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day
- 3/5/2014 8:39:53 AM
- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), which recently received Food and Drug Administration (FDA) accelerated approval of NORTHERATM (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), supports raising awareness for Rare Disease Day as a member of National Organization for Rare Disorders (NORD). "Chelsea is proud to be a …
- Twitter ’big data’ can be used to monitor HIV and drug-related behavior, UCLA study shows
- 2/28/2014 10:46:05 AM
- Real-time social media like Twitter could be used to track HIV incidence and drug-related behaviors with the aim of detecting and potentially preventing outbreaks, a new UCLA-led study shows. The study, published in the peer-reviewed journal Preventive Medicine, suggests it may be possible to predict sexual risk and drug use behaviors by monitoring tweets, mapping where …
- FAL Awards Third-party Accreditation to Course Providers
- 2/24/2014 11:00:00 AM
- The Foundation for Accredited Learning (FAL) has awarded third-party accreditation to new course providers in the environmental, health & safety fields. These providers are now listed in the searchable FAL provider database at www.accreditedlearning.org . FAL-accredited providers have demonstrated that their courses accomplish stated learning objectives. In awarding …
- UVDI & Clorox Healthcare Announce Partnership for Comprehensive Approach to Environmental Disinfection
- 2/19/2014 11:49:14 AM
- UltraViolet Devices, Inc. (UVDI) and Clorox Healthcare share a deep commitment to public health and a mission to help protect patients and reduce illnesses caused by healthcare-associated infections (HAIs). This month, the two companies entered a partnership designed to deliver an even more comprehensive surface disinfection solution. Known for their innovative line of …
- ACAC Posts 90% Retention Rate in 2013
- 2/19/2014 11:00:00 AM
- The American Council for Accredited Certification (ACAC) has published its retention rates for 2013, which show that 90% of certificants expiring last year elected to recertify and retain their designations. By this measure, ACAC certifications were among the most valuable in the environmental industry in 2013. ACAC certifications are current for two years only, at which …
- Chelsea Therapeutics Issues Statement Regarding Postponement of NORTHERA(TM) (Droxidopa) NDA PDUFA Action Date Due to Severe Weather
- 2/16/2014 9:11:14 AM
- Chelsea Therapeutics International , Ltd. (Nasdaq:CHTP) issued the following statement regarding the U.S. Food and Drug Administration (FDA) Prescription Drug User Fee Act (PDUFA) action date for the Company’s NORTHERA™ (droxidopa) New Drug Application (NDA): "As a result of severe weather conditions leading to an office closure, FDA notified Chelsea Therapeutics that the …
- California Residents Turn to LA Testing for Microbial Testing of Crawl Spaces
- 2/14/2014 3:58:15 PM
- Garden Grove, CA, February 14th, 2014 Most homes and buildings in California are built either on a slab, with a basement or above a crawl space. For those built with a crawl space, the area under the building is in most cases rarely seen. In fact, many crawl spaces may go years without ever being inspected. When a moisture problem does develop in a crawl space, …
- California Residents Reminded of Potential Environmental Hazards Due to Remodeling Projects
- 2/12/2014 12:05:42 PM
- Garden Grove, CA, February 12th, 2014 California homeowners are known for taking on do-it-yourself (DIY) projects of all types. While these projects can bring new life to homes and increase their value, they can also expose building occupants to potential hazards that many people may not be aware of. Almost every type of renovation and remodeling project will generate …
- Healthier future for millions of children as India becomes polio-free
- 2/11/2014 3:06:21 PM
- NEW YORK/NEW DELHI – Today, millions of children have a better chance of a healthier future, as India marks the achievement of moving from being a polio-endemic country to polio-free. Experts once believed India was the most difficult place in the world to stop polio and would be the last country to accomplish eradication. Until 2009, India accounted for at least half the …
- LIVESTRONG Foundation Launches Global Social Innovation Competition Designed to Improve the Lives of People Affected by Cancer
- 2/11/2014 12:23:24 PM
- The LIVE STRONG Foundation is launching a unique global competition to generate innovations that advance its mission of improving the daily quality of life for people affected by cancer now. Beginning on World Cancer Day , " The Big C competition " aims to initiate an international movement in entrepreneurship by collaborating with social innovators to create …
- Researchers discover immune signature that predicts poor outcome in influenza patients
- 2/11/2014 11:03:06 AM
- St. Jude Children’s Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings also help explain why infants and toddlers are at elevated risk for flu complications. The research appears in the upcoming issue …
- « Previous
- 1
- Next »
